{"id":55521,"date":"2016-09-06T14:54:00","date_gmt":"2016-09-06T18:54:00","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=55521"},"modified":"2021-02-12T14:01:29","modified_gmt":"2021-02-12T19:01:29","slug":"dot-supervisor-training-live-webinar-training-dates","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/dot-supervisor-training-live-webinar-training-dates\/","title":{"rendered":"DOT Supervisor Training Live Webinar Training Dates"},"content":{"rendered":"\n<p>Reasonable Suspicion Training Webinar for Supervisors &#8211; This course trains supervisors on how to recognize the signs, symptoms and performance indicators of drug abuse and alcohol misuse.\u00a0 This is required training under <strong><a href=\"https:\/\/www.nationaldrugscreening.com\/dot-drug-test\/\">DOT regulations for supervisors<\/a><\/strong> of safety sensitive employees.All Webinars Include:<\/p>\n\n\n\n<ul><li>Pre-Training Review Materials Will Be Provided to all Registered Attendees<\/li><li>Certificates of Training Will Be Issued<\/li><li>Pre-Registration is Required<\/li><li>Limited Seating<\/li><li>Appropriate For&nbsp;FMCSA and FAA transportation modes<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><a href=\"https:\/\/www.nationaldrugscreening.com\/trainings\/dot-supervisor-training-live-webinar-training-dates\/\">Click Here to View Available Dates and to Register Now<\/a><\/h2>\n\n\n\n<p>FOR QUESTIONS OR DETAILS CALL<a class=\"\" href=\"tel:8668434545\">&nbsp;866-843-4545&nbsp;<\/a>\u2022&nbsp;<a href=\"https:\/\/www.nationaldrugscreening.com\/trainings\/dot-supervisor-training-live-webinar-training-dates\/\">CONTACT US<\/a><\/p>\n\n\n\n<p>ALL REGISTRATIONS WILL BE CONFIRMED VIA E-MAIL.<\/p>\n\n\n\n<p><strong>This course meets the Supervisor training requirements of DOT 49 CFR Part 382.603 and DOT 14 CFR part 120.115&nbsp;and includes training on how to&nbsp;<\/strong>recognize<strong>&nbsp;the signs, symptoms and performance indicators of drug abuse and alcohol misuse.&nbsp; This training is designed to enable a supervisor to determine whether reasonable suspicion exists to require testing.<\/strong><\/p>\n\n\n\n<p>A Supervisor\u2019s Guide to Reasonable Suspicion Testing &#8211; Webinar Training.&nbsp; In addition to the information on the signs and symptoms of the five most commonly abused drugs &#8211; marijuana, cocaine, amphetamines, opiates &amp; PCP &#8211; and alcohol, the course covers Club Drugs and inhalants which are growing workplace problems.&nbsp; Also covered is a step-by-step confrontation process, information on the reasons for testing, refusal to test and reasonable suspicion testing situations.<\/p>\n\n\n\n<p>Two-hour Live webinar plus additional training materials.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Drug Training<\/strong><\/h3>\n\n\n\n<p>Supervisors who will determine when an employee is subject to drug testing based on reasonable suspicion must receive at least 60 minutes of initial training, including specific training on:<\/p>\n\n\n\n<ul><li>The effects and consequences of drug use on individual health, safety, and work environment<\/li><li>The manifestations and behavioral cues that may indicate drug use and abuse<\/li><li>Specific, contemporaneous physical, behavioral, and performance indicators of probable drug use<\/li><\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Alcohol training<\/strong><\/h3>\n\n\n\n<ul><li>Supervisors who make reasonable suspicion determinations for alcohol testing must receive at least 60 minutes of training on the physical, behavioral, speech, and performance indicators of probable alcohol misuse.<\/li><li>Both FMCSA and FAA set drug and alcohol education and training requirements for safety-sensitive employees and supervisors who will make reasonable suspicion testing decisions. This webinar will meet that requirement for your supervisors.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><a href=\"https:\/\/www.nationaldrugscreening.com\/trainings\/dot-supervisor-training-live-webinar-training-dates\/\">Click Here to View Available Dates and to Register Now<\/a><\/h2>\n\n\n\n<p>FOR QUESTIONS OR DETAILS CALL<a class=\"\" href=\"tel:8668434545\">&nbsp;866-843-4545&nbsp;<\/a>\u2022&nbsp;<a href=\"https:\/\/www.nationaldrugscreening.com\/trainings\/dot-supervisor-training-live-webinar-training-dates\/\">CONTACT US<\/a><\/p>\n\n\n\n<p>ALL REGISTRATIONS WILL BE CONFIRMED VIA E-MAIL.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reasonable Suspicion Training Webinar for Supervisors &#8211; This course trains supervisors on how to recognize the signs, symptoms and performance indicators of drug abuse and alcohol misuse.\u00a0 This is required training under DOT regulations for supervisors of safety sensitive employees.All Webinars Include: Pre-Training Review Materials Will Be Provided to all Registered Attendees Certificates of Training [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":53630,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"54862,55058,51456,51178,51160,51100","_relevanssi_noindex_reason":"","footnotes":""},"categories":[78],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55521"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=55521"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/53630"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=55521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=55521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=55521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}